‘Anti-blood clot’ fermented soybean extract safe, says EFSA

By Annie Harrison-Dunn contact

- Last updated on GMT

The novel food application was forwarded onto EFSA after member states expressed concern about the ingredient's long-term impact on blood coagulation. ©iStock/somersault18:24
The novel food application was forwarded onto EFSA after member states expressed concern about the ingredient's long-term impact on blood coagulation. ©iStock/somersault18:24

Related tags: Blood, European food safety authority

A fermented soybean extract that claims to help prevent blood clots is safe for use in food supplements, the European Food Safety Authority (EFSA) has concluded following a novel food application from a Japanese company that sparked member state concerns.

Japan Bio Science Laboratory (JBSL) says its ingredient has an “anti-blood-clotting effect, controls blood pressure, and lowers blood viscosity to improve circulation, making it an effective supplement to combat heart disease”.

Yet following a positive opinion on the novel food from the Belgian authority, member states expressed concern about the ingredient's long-term impact on blood clotting. 

One case report​ showed a patient on anti-hypertensive agents and low-dose aspirin for secondary stroke prevention experienced an "acute cerebellar haemorrhage and cerebral microbleeds" ​after taking nattokinase alongside the medicines.  

The dossier was forwarded onto EFSA by the European Commission to address the concerns, which also included potential allergenicity and substantiation of whether the ingredient was absorbed into the blood stream when consumed orally. 

Yet EFSA said in its final opinion​ the fermented soybean extract NSK-SD – which contains the traditional Japanese ingredient nattokinase – was safe under the conditions put forward by the Osaka-headquartered company.

Isoflavones soy soya bean
©iStock

The company proposed a daily maximum intake of 100 mg of NSK-SD as a food supplement among the target population of healthy over 35s, excluding pregnant and lactating women. 

Taking into account the no observed adverse effect level (NOAEL) of 1,000 mg/kg body weight per day in the subchronic toxicity study in rats, and considering the proposed maximum intake level for the novel food, the Panel concludes that the margin of exposure is sufficient,” ​wrote EFSA's Dietetic Products, Nutrition and Allergies (NDA) panel. 

The ingredient

NSK-SD contains nattokinase, which is a serine protease composed of 275 amino acid residues.

Nattokinase was originally isolated from the traditional Japanese breakfast food 'natto' - soybeans fermented with Bacillus subtilis var. natto​.

The ingredient is already sold in the US and 11 other countries.

Last year the company released research results​ showing the ingredient’s ability to curb the formation of abnormal blood clots and therefore benefit blood flow.

Related news

Show more

Related products

show more

Pronativ® | An Essential Nutrient-Rich Protein

Pronativ® | An Essential Nutrient-Rich Protein

Lactalis Ingredients | 06-Jul-2020 | Technical / White Paper

Differentiate your protein product with a nutrient-rich protein ingredient.
Pronativ® native whey protein, produced by Lactalis Ingredients, is...

Reverse immune ageing with HRB probiotics formula

Reverse immune ageing with HRB probiotics formula

Morinaga Milk Industry Co., Ltd. | 29-Jun-2020 | Application Note

As the pace of population ageing around the world is rising dramatically, more people want to age healthily. Increasingly, consumer are on the search for...

Robuvit® Boosts Recovery Following Surgery

Robuvit® Boosts Recovery Following Surgery

Horphag Research | 22-Jun-2020 | Clinical Study

New research found Robuvit® French oak extract improves general health, mood and social functioning of post-surgery patients. Robuvit®’s antioxidative...

Related suppliers

Follow us

Products

View more

Webinars